ESOPJun 5, 2026, 04:31 PM
ORIC Pharmaceuticals Grants Equity Inducement to 2 New Employees
AI Summary
ORIC Pharmaceuticals announced it granted a total of 34,800 non-qualified stock options and 5,900 restricted stock units to two new non-executive employees on June 1, 2026. These inducement grants were made pursuant to the company's 2022 Inducement Equity Incentive Plan, subject to the recipients' continued employment. The grants were approved by ORIC's Compensation Committee as a material inducement to employment.
Key Highlights
- ORIC Pharmaceuticals granted 34,800 non-qualified stock options.
- The company also granted 5,900 restricted stock units (RSUs).
- These inducement grants were made to two new non-executive employees.
- Grants were effective on June 1, 2026.
- Stock options vest 25% after one year, then 1/36th monthly thereafter.
- Restricted stock units vest one-third on each of the first three anniversaries.
- Grants were approved by the Compensation Committee per Nasdaq Rule 5635(c)(4).
Price Impact
More from ORIC